Abstract:Herein, redox and pH dual-responsive poly(glutamic acid) micelle-encapsulated doxorubicin (DOX) was developed in this report. First, methoxy poly(ethylene glycol)-block-poly(glutamic acid) (PEG-SS-PG) linked by a disulfide bond was synthesized through ring-opening polymerization of L-glutamic acid gamma-benzyl ester carboxyanhydride using terminal aminosylated poly(ethylene glycol) (PEG-SS-NH2) as an initiator. After that, PEG-SS-PG was assembled with doxorubicin (DOX) by a simple mixing to form tight PEG-SS-PG/DOX micelles by virtue of the electrostatic interaction between carboxylic acid groups of PEG-SS-PG and amine groups of DOX. Transmission electron microscopy (TEM) and dynamic light scattering (DLS) characterization indicated that the micelles have a spherical structure with an average particle size of about 70 nm. The drug loading efficiency (DLE) was measured to be 92.3 wt %. The release behavior of PEG-SS-PG/DOX was checked in the presence of glutathione (GSH) and different pH. The results showed that about 90% DOX was released within 36 h under the combined action of high GSH concentration and low pH, while less than 25% DOX was released at pH 7.4 in the absence of GSH. These data confirmed the glutathione and pH dual-responsiveness of PEG-SS-PG/DOX micelles. The micelles could be internalized by cancer cells, as revealed by confocal laser scanning microscopy (CLSM) and flow cytometry (FCM). The pharmacokinetics and biodistribution of the PEG-SS-PG/DOX micelles were further investigated in detail. Compared with free DOX, PEG-SS-PG/DOX micelles improved the biodistribution of DOX and prolonged blood circulation time. Finally, in vivo antitumor efficacy was studied using 4T1 breast tumor-bearing BALB/c mice. It was found that the tumor inhibition rate of PEG-SS-PG/DOX was up to 86.32%, indicating greatly effective antitumor performance. Taken together, PEG-SS-PG micelles can encapsulate DOX via electrostatic interaction to form tight micelles and possess redox and pH dual-responsive release of DOX and highly effective inhibition of tumor growth, which have potential application for the treatment of tumors.

Simple Fabrication of Glutathione-Responsive Pegylated Micellar Nanocarriers for Dual Drugs Delivery

Therapeutic Polymeric Nanomedicine: GSH-responsive Release Promotes Drug Release for Cancer Synergistic Chemotherapy.

Glutathione-Responsive Polymeric Micelles Formed by A Biodegradable Amphiphilic Triblock Copolymer for Anticancer Drug Delivery and Controlled Release

Self-Assembled Micelles Of Peg-Poly(Disulfide Carbamate Amine) Copolymers For Intracellular Dual-Responsive Drug Delivery

Reduction-sensitive Micelles with Sheddable PEG Shells Self-Assembled from a Y-shaped Amphiphilic Polymer for Intracellular Doxorubicine Release.

One-pot Synthesis of Glutathione-Responsive Amphiphilic Drug Self-Delivery Micelles of Doxorubicin-Disulfide-methoxy Polyethylene Glycol for Tumor Therapy.

Ph and GSH Dual-Responsive Drug-Controlled Nanomicelles for Breast Cancer Treatment.

Novel PLGGE Graft Polymeric Micelles for Doxorubicin Delivery

Chemoenzymatic Synthesis of Dual-Responsive Graft Copolymers for Drug Delivery: Long-Term Stability, High Loading and Cell Selectivity.

Reduction-Responsive Cross-Linked Micelles Based on Pegylated Polypeptides Prepared Via Click Chemistry

Redox and pH Dual-Responsive Polypeptide Micelles for Doxorubicin Delivery with Enhanced Anticancer Efficacy

Redox-Mediated Dissociation of Peg-Polypeptide-Based Micelles for On-Demand Release of Anticancer Drugs

Dual‐responsive Crosslinked Micelles of a Multifunctional Graft Copolymer for Drug Delivery Applications

Preparation of a Camptothecin Prodrug with Glutathione-Responsive Disulfide Linker for Anticancer Drug Delivery.

Acid-sensitive PEG-removable Nanoscale Liposomes for Delivery of Doxorubicin in A549/ADR Therapy

High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

Leakage-free DOX/PEGylated Chitosan Micelles Fabricated Via Facile One-Step Assembly for Tumor Intracellular Ph-Triggered Release.

GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.

Self-Assembled Micelles from an Amphiphilic Hyperbranched Copolymer with Polyphosphate Arms for Drug Delivery

Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.